| Website | tif.net/portfolio... |
| Category | BioTech |
| Phone | 949.450.0250 |
| Employees | |
| Founded | 2006 |
| Series C, 6/10 Longitude Capital Accuitive Medical Ventures Carlyle Group SV Life Sciences Rho Capital Partners | $35M |
AqueSys is developing a proprietary surgical device for the treatment of glaucoma. Glaucoma is the second leading cause of blindness worldwide and affects up to 65 million individuals.
